News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
305,959 Results
Type
Article (16592)
Company Profile (135)
Press Release (289232)
Section
Business (101007)
Career Advice (579)
Deals (24112)
Drug Delivery (74)
Drug Development (39541)
Employer Resources (54)
FDA (7099)
Job Trends (7344)
News (175116)
Policy (15463)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (553)
Adcomms (6)
Allergies (31)
Alliances (25795)
ALS (36)
Alzheimer's disease (410)
Antibody-drug conjugate (ADC) (49)
Approvals (7130)
Artificial intelligence (108)
Autoimmune disease (7)
Automation (4)
Bankruptcy (180)
Best Places to Work (5312)
BIOSECURE Act (9)
Biosimilars (56)
Biotechnology (65)
Bladder cancer (18)
Brain cancer (16)
Breast cancer (83)
Cancer (663)
Cardiovascular disease (73)
Career advice (506)
Career pathing (15)
CAR-T (28)
Cell therapy (100)
Cervical cancer (5)
Clinical research (33134)
Collaboration (372)
Compensation (147)
Complete response letters (16)
COVID-19 (903)
CRISPR (19)
C-suite (117)
Cystic fibrosis (36)
Data (662)
Denatured (15)
Depression (12)
Diabetes (85)
Diagnostics (1941)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (57)
Drug pricing (66)
Drug shortages (15)
Duchenne muscular dystrophy (35)
Earnings (38504)
Editorial (13)
Employer branding (5)
Employer resources (48)
Events (40632)
Executive appointments (390)
FDA (7531)
Featured Employer (22)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (245)
Gene editing (38)
Generative AI (8)
Gene therapy (113)
GLP-1 (394)
Government (1448)
Grass and pollen (2)
Guidances (20)
Healthcare (5048)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (44)
Indications (14)
Infectious disease (945)
Inflammatory bowel disease (68)
Inflation Reduction Act (6)
Influenza (17)
Intellectual property (50)
Interviews (72)
IPO (7302)
IRA (31)
Job creations (2289)
Job search strategy (460)
Kidney cancer (6)
Labor market (11)
Layoffs (228)
Leadership (5)
Legal (3917)
Liver cancer (23)
Lung cancer (99)
Lymphoma (54)
Machine learning (1)
Management (18)
Manufacturing (163)
MASH (29)
Medical device (2820)
Medtech (2822)
Mergers & acquisitions (17165)
Metabolic disorders (270)
Multiple sclerosis (22)
NASH (14)
Neurodegenerative disease (25)
Neuropsychiatric disorders (10)
Neuroscience (600)
NextGen: Class of 2025 (2126)
Non-profit (694)
Northern California (770)
Now hiring (9)
Obesity (160)
Opinion (137)
Ovarian cancer (21)
Pain (52)
Pancreatic cancer (16)
Parkinson's disease (47)
Partnered (8)
Patents (112)
Patient recruitment (31)
Peanut (10)
People (31872)
Pharmaceutical (68)
Pharmacy benefit managers (12)
Phase I (8759)
Phase II (14072)
Phase III (12560)
Pipeline (442)
Podcasts (50)
Policy (61)
Postmarket research (1445)
Preclinical (3525)
Press Release (25)
Prostate cancer (47)
Psychedelics (10)
Radiopharmaceuticals (138)
Rare diseases (165)
Real estate (3007)
Recruiting (19)
Regulatory (10953)
Reports (16)
Research institute (663)
Resumes & cover letters (75)
Rett syndrome (2)
RNA editing (1)
RSV (7)
Schizophrenia (44)
Series A (46)
Series B (13)
Service/supplier (5)
Sickle cell disease (30)
Southern California (782)
Special edition (8)
Spinal muscular atrophy (84)
Sponsored (9)
Startups (1906)
State (2)
Stomach cancer (3)
Supply chain (33)
The Weekly (33)
United States (7900)
Vaccines (190)
Venture capitalists (16)
Webinars (10)
Weight loss (113)
Women's health (8)
Worklife (3)
Date
Today (57)
Last 7 days (238)
Last 30 days (1194)
Last 365 days (14306)
2025 (3216)
2024 (14807)
2023 (16879)
2022 (22969)
2021 (23965)
2020 (22583)
2019 (18078)
2018 (14284)
2017 (16082)
2016 (15013)
2015 (17639)
2014 (13918)
2013 (11714)
2012 (12699)
2011 (13278)
2010 (12101)
Location
Africa (357)
Alabama (14)
Alaska (1)
Arizona (61)
Arkansas (3)
Asia (22453)
Australia (2954)
California (1902)
Canada (987)
China (238)
Colorado (73)
Connecticut (93)
Delaware (55)
Europe (45205)
Florida (351)
Georgia (49)
Idaho (14)
Illinois (197)
India (13)
Indiana (152)
Iowa (2)
Japan (89)
Kansas (57)
Kentucky (13)
Louisiana (3)
Maine (6)
Maryland (278)
Massachusetts (1590)
Michigan (48)
Minnesota (102)
Missouri (24)
Montana (9)
Nebraska (7)
Nevada (8)
New Hampshire (13)
New Jersey (781)
New Mexico (8)
New York (547)
North Carolina (447)
North Dakota (3)
Northern California (770)
Ohio (59)
Oklahoma (4)
Oregon (19)
Pennsylvania (465)
Puerto Rico (8)
Rhode Island (11)
South America (586)
South Carolina (3)
Southern California (782)
Tennessee (64)
Texas (246)
Utah (48)
Virginia (75)
Washington D.C. (30)
Washington State (160)
West Virginia (2)
Wisconsin (19)
305,959 Results for "processa pharmaceuticals heatwurx acquired promet".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
March 19, 2025
·
1 min read
Press Releases
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
February 7, 2025
·
1 min read
Press Releases
Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
January 30, 2025
·
2 min read
Press Releases
Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
January 27, 2025
·
5 min read
BioCapital
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
Processa Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, announced that management will be participating in the EF Hutton Annual Global Conference being held May 15, 2024 at The Plaza Hotel in New York City.
May 6, 2024
·
2 min read
Press Releases
Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results
October 31, 2024
·
7 min read
Business
Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
Processa Pharmaceuticals, Inc. today announced that it has named Steven Cha, M.D. as Senior Vice President of Clinical Research.
April 30, 2024
·
4 min read
BioCapital
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Processa Pharmaceuticals, Inc. announces that George Ng, Chief Executive Officer, will present a corporate update at the MedInvest Biotech and Pharma Investor Conference.
March 28, 2024
·
3 min read
BioCapital
Processa Pharmaceuticals to Present at the Biotech Showcase 2024
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), announces that George Ng, Chief Executive Officer, will present a corporate overview at the Biotech Showcase 2024.
January 2, 2024
·
3 min read
BioCapital
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
Processa Pharmaceuticals, Inc. announces that the Company will have two posters at the American Association for Cancer Research Annual Meeting 2024 in San Diego from April 5-10, 2024.
March 25, 2024
·
3 min read
1 of 30,596
Next
